environment.

Today, critical operations depend on the human body being present in spaces that are fundamentally hostile to it - and to which it is fundamentally hostile. Hoods, gloveboxes, and isolators are workarounds - they limit throughput, expose operators, and don't scale. AlterEcho removes human presence from the point of operation while preserving the judgment and flexibility that complex procedures demand.

Every operation performed through the platform captures structured data - from environments that have never been instrumented at this level before - building the foundation for embodied AI that evolves from human-guided teleoperation toward autonomous capability over time.

This redefines who can do this work and how. Physically demanding, high-risk roles become precision robot piloting - reducing fatigue and exposure, and opening the field to a broader workforce.

AlterEcho serves pharmaceutical manufacturers, advanced therapy producers, high-risk research laboratories, and clinical settings - wherever the conditions make human presence untenable.

The outcome: safer operations, reduced contamination risk, fewer rejected batches, and controlled environments transformed from bottlenecks into remotely operated, intelligent workspaces.

Founded by ex-Novo Nordisk robotics and AI engineers. Backed by Techstars and Innovation Fund Denmark. The platform is hardware-agnostic, designed to work across robot brands and models, with a working dual-arm prototype today. SXSW 2026 Robotics & Intelligent Systems Pitch Competition winner. EU-Startups Summit 2026 Pitch Competition winner.